Notice to Extend the Expiration Date for PAR-17-214 "Limited Competition: Analysis of Data from NIA's Alzheimer's Disease Sequencing Project Follow-Up Study (U01)"
Notice NOT-AG-20-021 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 20, 2020 Category: Research Source Type: funding
Alzheimers Disease Research Centers (P30 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-21-019 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for P30 Alzheimer's Disease Research Centers (ADRCs). NIA-designated ADRCs serve as major sources of discovery into the nature of Alzheimers disease and Alzheimer's disease-related dementias (AD/ADRD) and into the development of more effective approaches to prevention, diagnosis, care, and therapy. They contribute significantly to the development of shared resources that support dementia-relevant research, and they collaborate and coordinate their research efforts with other NIH...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2020 Category: Research Source Type: funding
Notice of Special Interest: Digital Technology for Early Detection of Alzheimers Disease and Related Dementias
Notice NOT-AG-20-017 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2020 Category: Research Source Type: funding
Notice of Change in Application Types Allowed for PAR-19-070 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
Notice NOT-AG-20-018 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 4, 2020 Category: Research Source Type: funding
Notice of Change in Application Types Allowed for PAR-19-071 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)
Notice NOT-AG-20-019 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 3, 2020 Category: Research Source Type: funding
Alzheimers Disease Sequencing Project Functional Genomics Consortium (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-21-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports concerted efforts that take a multipronged, team science strategy and apply high throughput, genome-wide approaches to systematically discover and characterize functional genomic and epigenomic elements; and elucidate and validate their functional roles and mechanisms of action underpinning the heterogeneity, pathogenesis, and progression of Alzheimers disease andrelated dementias (AD/ADRD). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 25, 2020 Category: Research Source Type: funding
National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-110 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications specific to infrastructure that will support the storage, analysis, and sharing of primary and secondary data for the genetics and genomics of Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 7, 2020 Category: Research Source Type: funding
National Alzheimers Coordinating Center (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-21-014 from the NIH Guide for Grants and Contracts. This FOA invites applications for a National Alzheimer's Coordinating Center (NACC) whose purpose is to serve NIA and the Alzheimer's disease (AD) and Alzheimer's disease- related dementias (AD/ADRD) field as 1) a national data resource, collecting data from the Alzheimer's Disease Research Centers (ADRCs), affiliated data, and sample repositories; 2) a facilitator of current and future AD/ADRD research; and 3) the central hub for organizing and enabling communication within and outside the ADRC program, including annual meetings and steering...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2020 Category: Research Source Type: funding
Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-21-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U24 Cooperative Agreement applications aiming to establish several mis-folded protein polymorphisms resource networks in the area of Alzheimer's disease and its related dementias (AD/ADRD). The central goal of these resource networks is to standardize and distribute seed, oligomers, and fibrils to other investigators in order to clarify and improve the reproducibility of experiments in AD/ADRD. For the past several years, many studies have developed assays and reagents to understand the biop...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 27, 2020 Category: Research Source Type: funding
Harmonization of Alzheimers Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-099 from the NIH Guide for Grants and Contracts. The National Institute on Aging (NIA) invites applications specific to infrastructure that will support, under a single cooperative agreement (U24), phenotypic data harmonization on subjects with Alzheimer's Disease Sequencing Project (ADSP) genetic and genomic data. These data will become a long-lived legacy data set that will be perpetually curated. The FOA will fund a single vanguard network of researchers with expertise in genetics, epidemiology, and clinical specialties who will work with the ADSP and with study cohort leads on data harmoni...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2020 Category: Research Source Type: funding
Limited Competition: National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-21-005 from the NIH Guide for Grants and Contracts. The National Institute on Aging invites applications to renew an ongoing NIA-supported cooperative agreement, the National Centralized Repository for Alzheimer's Disease and Related Dementias. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 13, 2020 Category: Research Source Type: funding
New/Unconventional Animal Models of Alzheimers Disease (R24 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-21-003 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites research to develop, characterize, and validate new, unconventional, or innovative non-rodent mammalian models of late-onset (sporadic) Alzheimer's Disease (AD). These new models are expected torecapitulate molecular, cellular, neuropathological, behavioral, and/or cognitive hallmarks and aspects of late-onset AD.Research supported under this FOA is expected to provide new investigativetools to identify the gaps in current knowledge related to molecular mechanisms of late-onset AD and identi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 13, 2020 Category: Research Source Type: funding
Notice of Special Interest: Alzheimers-focused administrative supplements for NIH/NIDDK grants that are not focused on Alzheimers disease
Notice NOT-DK-20-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 13, 2020 Category: Research Source Type: funding
White Matter Lesion Etiology of Dementia in the U.S. Including in Health Disparity Populations (U19 Clinical Trial not Allowed)
Funding Opportunity RFA-NS-20-013 from the NIH Guide for Grants and Contracts. Despite established associations between white matter lesions and cognitive impairment including dementia, the volume, anatomical location, and other key cellular and molecular characteristics of white matter lesions that are both necessary and sufficient are unknown, as are the comorbid clinical factors that may modify (including protect from) these effects. Therefore, this initiative will support one large prospective clinical research study in the U.S. studying individuals with white matter lesions at risk for cognitive decline to determin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 30, 2019 Category: Research Source Type: funding
Notice of Special Interest: Alzheimers-focused Administrative Supplements for NIH/NCI Grants that are not focused on Alzheimers Disease
Notice NOT-CA-20-019 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 16, 2019 Category: Research Source Type: funding
